Quality by design‐engineered reversed‐phase high‐performance liquid chromatography method development and validation for simultaneous estimation of neomycin sulfate and beclomethasone dipropionate in bulk and pharmaceutical dosage form
SEPARATION SCIENCE PLUS · 2024-06 · 7 (6)
DOI: 10.1002/sscp.202400001 ↗Kurz gefasst
Fachartikel in der Zeitschrift SEPARATION SCIENCE PLUS, online erschienen am 10.05.2024. Verfasst von Shivesh Dessai und 4 weiteren Autor:innen. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
The aim of this study was to develop and validate a robust reversed‐phase high‐performance liquid chromatography (RP‐HPLC) method for the simultaneous estimation of neomycin sulfate (NEO) and beclomethasone dipropionate (BECLO) in both bulk drug and pharmaceutical dosage forms. The analysis was conducted using the Box‐Behnken design. The separation of NEO and BECLO was conducted on a Phenomenex Luna C‐18 column (4.6 × 150 mm, 5 µm), employing a mobile phase comprising a mixture of methanol and trifluoroacetic acid in a ratio of 88:12% v/v. The separation was performed at a flow rate of 0.6 mL/min. NEO and BECLO were analyzed at a wavelength of 240 nm employing a photodiode array detector. The validation of the methodology followed the guidelines outlined in the International Council for Harmonization Q2 R (1). The validation process involved assessing critical parameters such as linearity, accuracy, system suitability, precision, and robustness. The results for each parameter were found to be within the acceptable range. The results indicate that the established RP‐HPLC method can effectively be employed for the routine analysis of NEO and BECLO in bulk drug and pharmaceutical dosage forms.
Zitieren
APA
Dessai, S., Mannur, V. S., Koli, R., Dhond, M., & Badiger, P. (2024). Quality by design‐engineered reversed‐phase high‐performance liquid chromatography method development and validation for simultaneous estimation of neomycin sulfate and beclomethasone dipropionate in bulk and pharmaceutical dosage form. SEPARATION SCIENCE PLUS, 7(6). https://doi.org/10.1002/sscp.202400001
Vancouver
Dessai S, Mannur VS, Koli R, Dhond M, Badiger P. Quality by design‐engineered reversed‐phase high‐performance liquid chromatography method development and validation for simultaneous estimation of neomycin sulfate and beclomethasone dipropionate in bulk and pharmaceutical dosage form. SEPARATION SCIENCE PLUS. 2024;7(6). doi:10.1002/sscp.202400001
BibTeX
@article{Dessai2024,
author = {Dessai, Shivesh and Mannur, Vinod S. and Koli, Rahul and Dhond, Manasi and Badiger, Poorvika},
title = {Quality by design‐engineered reversed‐phase high‐performance liquid chromatography method development and validation for simultaneous estimation of neomycin sulfate and beclomethasone dipropionate in bulk and pharmaceutical dosage form},
journal = {SEPARATION SCIENCE PLUS},
year = {2024},
volume = {7},
number = {6},
doi = {10.1002/sscp.202400001}
}
EUVIMED